
Biosimilar boom ahead: Patent expirations set to reshape the global biologics market
Biosimilar boom ahead: Patent expirations set to reshape the global biologics market May 1, 2025 | Thursday | Analysis | By Cytiva With over $200B in biologic drug revenue at stake by 2030, biosimilar developers face an urgent opportunity to deliver …